Tokyo Tape
Sign in
← Soiken Holdings

Quarterly report · Q2

2385.TEDINET S100SUZ2
Period2023-07-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥2.8bn2023-07-01 → 2023-12-31Cons.Net sales
Revenue¥8.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥4.2bn2022-07-01 → 2022-12-31Cons.Net sales
Operating income−¥455m2023-07-01 → 2023-12-31Cons.Operating income
Operating income¥345m2022-07-01 → 2022-12-31Cons.Operating income
Ordinary income−¥449m2023-07-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥727m2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥345m2022-07-01 → 2022-12-31Cons.Ordinary income
Profit before tax−¥449m2023-07-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥345m2022-07-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)−¥488m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥452m2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥209m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income−¥489m2023-07-01 → 2023-12-31Cons.Profit loss
Net income¥213m2022-07-01 → 2022-12-31Cons.Profit loss
Total assets¥7.1bnat 2023-12-31Cons.Assets
Total assets¥8.2bnat 2023-06-30Cons.Assets
Total assets¥8.0bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥702mat 2023-12-31Cons.Liabilities
Total liabilities¥1.1bnat 2023-06-30Cons.Liabilities
Net assets / equity¥6.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-06-30Cons.Net assets
Net assets / equity¥6.9bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥4.7bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥5.9bnat 2023-06-30Cons.Cash and deposits
Cash & equivalents¥4.7bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.9bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.0bnat 2022-06-30dCons.Cash and cash equivalents
Operating cash flow−¥967m2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥102m2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥328m2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥10m2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥160m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥260m2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥130m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥130m2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥-18.652023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥1.52023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥17.272022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥82022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥7.472022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio89.9%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio84.4%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 49
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥10m
Reconciling Itemsreconcilingrevenue external2023-07-01 → 2023-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥11m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥156m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥176m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥1m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥779m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥72m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2023-07-01 → 2023-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2023-07-01 → 2023-12-31−¥270m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2023-07-01 → 2023-12-31¥165m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2023-07-01 → 2023-12-31¥157m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥8m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2023-07-01 → 2023-12-31−¥701,000
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2023-07-01 → 2023-12-31¥337m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2023-07-01 → 2023-12-31¥43m
—segment totalrevenue2023-07-01 → 2023-12-31¥2.9bn
—segment totalrevenue external2023-07-01 → 2023-12-31¥2.8bn
—segment totalrevenue intersegment2023-07-01 → 2023-12-31¥11m
—segment totalsegment profit2023-07-01 → 2023-12-31−¥299m
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥2m
Reconciling Itemsreconcilingrevenue external2022-07-01 → 2022-12-31¥900,000
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥3m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥155m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥258m
jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥32m
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥2.0bn
jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31¥398m
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentrevenue external2022-07-01 → 2022-12-31¥1.4bn
jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segmentsegment profit2022-07-01 → 2022-12-31−¥18m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue2022-07-01 → 2022-12-31¥279m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue external2022-07-01 → 2022-12-31¥277m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥3m
jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segmentsegment profit2022-07-01 → 2022-12-31¥43m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentrevenue external2022-07-01 → 2022-12-31¥314m
jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segmentsegment profit2022-07-01 → 2022-12-31¥45m
—segment totalrevenue2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue external2022-07-01 → 2022-12-31¥4.2bn
—segment totalrevenue intersegment2022-07-01 → 2022-12-31¥3m
—segment totalsegment profit2022-07-01 → 2022-12-31¥500m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 441
ItemContextValueUnit
Gross profitPrior1YTDDuration2023187000JPY
Gross profitCurrentYTDDuration1378880000JPY
Selling general and administrative expensesPrior1YTDDuration1678663000JPY
Selling general and administrative expensesCurrentYTDDuration1833966000JPY
Operating incomePrior1YTDDuration344523000JPY
Operating incomeCurrentYTDDuration-455085000JPY
Interest income noiPrior1YTDDuration183000JPY
Interest income noiCurrentYTDDuration31000JPY
Compensation income for damage noiPrior1YTDDuration216000JPY
Compensation income for damage noiCurrentYTDDuration3719000JPY
Other noiPrior1YTDDuration993000JPY
Other noiCurrentYTDDuration3010000JPY
Non operating incomePrior1YTDDuration1393000JPY
Non operating incomeCurrentYTDDuration6760000JPY
Other noePrior1YTDDuration566000JPY
Other noeCurrentYTDDuration965000JPY
Non operating expensesPrior1YTDDuration566000JPY
Non operating expensesCurrentYTDDuration965000JPY
Ordinary incomePrior1YTDDuration345351000JPY
Ordinary incomeCurrentYTDDuration-449290000JPY
Loss on retirement of noncurrent assets elPrior1YTDDuration61000JPY
Loss on retirement of noncurrent assets elCurrentYTDDuration－JPY
Loss on sales of noncurrent assets elPrior1YTDDuration－JPY
Loss on sales of noncurrent assets elCurrentYTDDuration134000JPY
Extraordinary lossPrior1YTDDuration61000JPY
Extraordinary lossCurrentYTDDuration134000JPY
Income before income taxesPrior1YTDDuration345289000JPY
Income before income taxesCurrentYTDDuration-449425000JPY
Income taxes currentPrior1YTDDuration107527000JPY
Income taxes currentCurrentYTDDuration3871000JPY
Income taxes deferredPrior1YTDDuration24456000JPY
Income taxes deferredCurrentYTDDuration35235000JPY
Income taxesPrior1YTDDuration131984000JPY
Income taxesCurrentYTDDuration39106000JPY
Profit lossPrior1YTDDuration213305000JPY
Profit lossCurrentYTDDuration-488531000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration4100000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-645000JPY
Profit loss attributable to owners of parentPrior1YTDDuration209204000JPY
Profit loss attributable to owners of parentCurrentYTDDuration-487886000JPY
Profit lossPrior1YTDDuration213305000JPY
Profit lossCurrentYTDDuration-488531000JPY
Comprehensive incomePrior1YTDDuration213305000JPY
Comprehensive incomeCurrentYTDDuration-488531000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration209204000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration-487886000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration4100000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-645000JPY
Income before income taxesPrior1YTDDuration345289000JPY
Income before income taxesCurrentYTDDuration-449425000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-06-30pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass